Dr. Kanapuru is a medical officer in the Division of Hematology Products in the Office of Hematology and Oncology Products (OHOP) in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA). Her professional interests include the treatment of hematological malignancies, geriatric oncology and patient-reported outcomes (PRO). She serves as the scientific liaison for geriatric hematology and the division PRO lead at OHOP.

Prior to joining the FDA, Dr. Kanapuru was in private hematology/oncology practice and has experience in adult and geriatric hematology and oncology.

Dr. Kanapuru received her medical degree from Chennai Medical College in India. She completed her fellowship in hematology and oncology at the University of Maryland Medical Center in Baltimore, and her residency in internal medicine at Harbor Hospital in Baltimore. During her fellowship she did her research training on mechanisms of unexplained anemia and cancer incidence in older adults at the National Institute of Aging, and co-authored multiple publications and book chapters. She is board-certified in hematology, medical oncology and internal medicine.